Single-Dose Fed Bioequivalence Study of Nisoldipine Extended-Release Tablets (40 mg; Mylan) and Sular® Extended-Release Tablets (40 mg; First Horizon) in Healthy Volunteers
Clinical trial NCT00979537 · COMPLETED
Trial details
- NCT number
- NCT00979537
- Sponsor
- Mylan Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2007-03-01
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.